#Budapest #Hungary #Rejuran #PharmaResearch

PharmaResearch Launches REJURAN in Hungary

PharmaResearch, the acclaimed South Korean pharmaceutical company, has taken a major step in expanding its global footprint by launching its renowned skin booster, REJURAN, in Hungary. This milestone was celebrated at a dedicated symposium held on September 14, 2026, at the prestigious Museum of Fine Arts in Budapest. The event attracted approximately 100 professionals from the field of aesthetic medicine, including dermatologists, plastic surgeons, and other specialists.

The choice of venue is particularly significant, as the Museum of Fine Arts is one of Hungary's premier national art institutions and reflects the brand's commitment to integrating art and science. During the symposium, experts from Korea, the Czech Republic, Slovakia, and Hungary came together to share their clinical experiences with REJURAN. Highlighted speakers included noted key opinion leaders from Korea like Dr. Hyun Jun Park and Dr. Kyu Ho Lee, who discussed the versatile applications of PN in skin regeneration.

The REJURAN product line includes several variants: the original REJURAN for facial treatments, REJURAN I specifically designed for sensitive areas like under the eyes, and REJURAN S, which targets wrinkles and scars. The symposium featured live demonstrations of these products, allowing attendees to gain firsthand insights into their application and effectiveness in clinical environments.

A notable trend in Hungary's aesthetic medicine sector has been the rising interest in treatments that emphasize skin quality, alongside traditional options such as botulinum toxin and hyaluronic acid fillers. With patients becoming more informed about the options available, there is a noticeable shift toward seeking natural results with minimal recovery time. This has led to increased interest among physicians in combining injectables with energy-based devices and other treatments for holistic approaches to aesthetics.

Following this launch event, PharmaResearch is poised to increase the distribution of its REJURAN products in Hungary through local partnerships. The company aims to expand its network of clinics and healthcare professionals across major cities, placing a strong emphasis on physician education and practical training to facilitate the integration of REJURAN into standard aesthetic practices.

A spokesperson from PharmaResearch emphasized that this launch is not just about entering a new market; it's an opportunity to exchange knowledge and clinical expertise developed in Korea while connecting with local physicians. The company remains committed to fostering scientific exchanges and enhancing educational initiatives as it continues to implement REJURAN in Hungary and other parts of Europe.

In conclusion, PharmaResearch's entry into Hungary with REJURAN signifies a growing recognition of the need for quality and innovation in aesthetic medicine. As the market continues to evolve and patient expectations rise, the symbiotic relationship between medical advancements and aesthetic desires will likely shape the future of skincare treatments in the region.